Growth Metrics

Trinity Biotech (TRIB) Return on Equity (2021 - 2022)

Trinity Biotech's Return on Equity history spans 2 years, with the latest figure at 0.2% for Q4 2022.

  • On a quarterly basis, Return on Equity fell 34.0% to 0.2% in Q4 2022 year-over-year; TTM through Dec 2022 was 0.2%, a 34.0% decrease, with the full-year FY2025 number at 0.01%, up 1.0% from a year prior.
  • Return on Equity hit 0.2% in Q4 2022 for Trinity Biotech, down from 0.03% in the prior quarter.
  • Over the last five years, Return on Equity for TRIB hit a ceiling of 1.09% in Q3 2021 and a floor of 0.83% in Q2 2021.